"10.1371_journal.pone.0082127","plos one","2013-12-23T00:00:00Z","Delphine Meynard; Chia Chi Sun; Qifang Wu; Wenjie Chen; Shanzhuo Chen; Caroline N Nelson; Michael J Waters; Jodie L Babitt; Herbert Y Lin","Program in Anemia Signaling Research, Division of Nephrology, Program in Membrane Biology, Center for Systems Biology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, United States of America; Institute for Molecular Bioscience, University of Queensland, St. Lucia, Australia","Conceived and designed the experiments: DM JLB HYL. Performed the experiments: DM CCS QW WC SC. Analyzed the data: DM JLB HYL. Wrote the paper: DM JLB HYL. Provided expertise on STAT5 and STAT5b plasmid: CNN MJW. Interpreted the data: DM JLB HYL.","CCS, JLB and HYL have ownership interest in a start-up company Ferrumax Pharmaceuticals, which has licensed technology from the Massachusetts General Hospital based on their work. DM, QW, WC, SC, CN, MW have none to declare. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2013","12","Delphine Meynard","DM",9,TRUE,3,5,3,3,TRUE,TRUE,FALSE,0,NA,FALSE
